LEGAL PROBLEMS ON DRUG QUALITY CONTROL IN THE DRUG LOGISTICS IN THAILAND
Main Article Content
Abstract
Assuring the quality of drugs throughout the drug supply chain, from the point of manufacture to the point of delivery to the patients is of extreme importance. There are many factors affecting the stability of drugs, ranging from the manufacturing process, the environmental conditions, such as,, temperature, light, and humidity encountered during transportation to distribution, storage and other activities in the logistics process.
In Thailand, the problems of drug degradation, drug contamination and other drug quality problems are continuously raised by the hospitals, drugstores and patients because some drugs were not properly transported, distributed and stored in accordance with the conditions required on the label of each drug during the logistics process ,despite the fact that the drugs are sensitive products and required special conditions, e.g. control over temperature, humidity, light, cleanness, sanitation, prevention of contamination and other factors encountered during transportation, distribution and storage.
This thesis, thus, aims to study the problems of Thai law on drug quality control, comparing them with foreign legislations, such as those of the United Kingdom and Singapore, as well as the guidelines of the World Health Organization and the European Union on the various stages of activities in the drug logistic chain, in order to propose an appropriate legislative solution in the Thai context.
Article Details
References
Sadler, Ian. Logistics and Supply Chain Integration. N.p.: Sage Publications, 2007.
ASEAN Secretariat. “The ASEAN Sectorial Mutual Recognition Arrangement for Good Manufacturing Practice (GMP) Inspection of Manufacturers of Medicinal Products.” ASEAN. http://www.asean.org/archive/documents/Agreement%20on%20MRA%20for%20GMP%20Pharmaceutical.pdf (accessed
May 29, 2015).
European Commission. “EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use.” http://ec.europa.eu/health/files/eudralex/vol-4/vol4-chap1_2013-01_en.pdf (accessed June 2, 2015).
European Commission. “Guidelines of 5 November 2013 on Good Distribution Practice of Medicinal Products for Human Use (Text with EEA relevance) (2013/C 343/01).” http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?
uri=OJ:C:2013:343:0001:0014:EN:PDF (accessed June 2, 2015).
Government Pharmaceutical Organization. “Good Manufacturing Practice:GMP.”
https://www.gpo.or.th/Default.aspx?PageContentMode=1&tabid=107 (accessed June 2, 2015).
Health Sciences Authority of Singapore. “Guidance Notes on Good Distribution Practice 2010.” http://www.hsa.gov.sg/content/dam/HSA/HPRG/
Manufacturing_Importation_Distribution/Guidelines-on-Good-Manufacturing-Practice-Standard-and-Good-Distribution-Practice-Standard/GUIDE-MQA-013-009.pdf (accessed June 2, 2015).
Health Sciences Authority of Singapore. Medicines Act (Chapter 176). http://www.hsa.gov.sg/content/dam/HSA/HPRG/Useful_Information_for_Applicants/Legislation/MEDICINES%20ACT.pdf (accessed June 2, 2015).
Healthcare Supply Chain Excellence Centre (LogHealth) Mahidol University. “Healthcare Logistics & Supply Chain – Status in Thailand.” http://www.nrct.go.th/th/Portals/0/data/ภค/2556/06/3รศ_ดร_ดวงพรรณ_คุณโสภณ.pdf (accessed June 2, 2015).
Kommanaboyina, Brahmaiah, and Rhodes, C. T.. “Trends in Stability Testing, with Emphasis on Stability During Distribution and Storage.” Drug Development and Industrial Pharmacy,(1999): 858. http://www.informahealthcare.com (accessed December 17, 2014).
Medical Dictionary. http://medical-dictionary.thefreedictionary.com/drug (accessed June 2, 2015).
Medicines and Healthcare Products Regulatory Agency. http://www.mhra.gov.uk/
Howweregulate/Medicines/Licensingofmedicines/ (accessed June 2, 2015).
Pharmaceutical Inspection Co-operation Scheme. “PIC/S Guide to Good Manufacturing Practice for Medicinal Products.” Picscheme. http://www.picscheme.org/publication.php (accessed June 2, 2015).
Vitasek, Kate. “Supply Chain Management Terms and Glossary.” (2013): 117. http://cscmp.org/sites/default/files/user_uploads/resources/downloads/glossary-2013.pdf (accessed June 2, 2015).
World Health Organization. “About Quality Assurance.” http://www.who.int/
medicines/areas/quality_safety/quality_assurance/about/en/ (accessed January 18, 2015).
World Health Organization. “WHO Good Distribution Practices for Pharmaceutical Products.” WHO Technical Report Series, No. 957.” (2010); 235-264. http://www.who.int/medicines/areas/quality_safety/quality_assurance/
GoodDistributionPracticesTRS957Annex5.pdf (accessed June 2, 2015).
World Health Organization. “WHO Good Manufacturing Practices for Pharmaceutical Products.” WHO Technical Report Series, No. 961.” (2011); 77-135. http://apps.who.int/prequal/info_general/documents/TRS908/WHO_TRS_
908-Annex9.pdf (accessed June 14, 2015).
สมชัยยา สุริฉันท์. “การเก็บรักษากับความคงตัวของยาและเภสัชภัณฑ์.” [Somchaiya Surichan. “Storage and Stability of a Drug Product”] http://www.gpo.or.th/rdi/html/stability.html (accessed June 2, 2015).
สำนักยาและวัตถุเสพติด. “การเฝ้าระวังปัญหาทางกายภาพของผลิตภัณฑ์ยาที่มีใช้ในสถานบริการสาธารณสุขปี พ.ศ. 2552-2554.” [Bureau of Drug and Narcotic. “Monitoring Physical Problems of Drugs Used in Health Centers in the Year 2009 – 2013.”] http://dmsc2.dmsc.moph.go.th/webroot/drug/qa30/problem/หนังสือปัญหาคุณภาพยา52-54.pdf (accessed January 18, 2015).
สำนักยาและวัตถุเสพติด. “ปัญหาคุณภาพยาที่ได้รับรายงานปี พ.ศ. 2555.” จดหมายข่าวศูนย์รวบรวมข้อมูลปัญหาคุณภาพยา 16, ฉ.1 (มกราคม – เมษายน 2556) [Bureau of Drug and Narcotic, Drug Quality Problems Reported in the Year 2012.” Drug Quality Problems Reporting Center Newsletter 16, no. 1 (January - April 2013)] http://dmsc2.dmsc.moph.go.th/webroot/drug/surveillance/newsletter/Newsletter16-1-2556.pdf (accessed January 18, 2015).
สำนักยาและวัตถุเสพติด. “ปัญหาคุณภาพยาที่ได้รับรายงานปี พ.ศ. 2556.” จดหมายข่าวศูนย์รวบรวมข้อมูลปัญหาคุณภาพยา 17, ฉ.1 (มกราคม – เมษายน 2557) [Bureau of Drug and Narcotic, Drug Quality Problems Reported in the Year 2013.” Drug Quality Problems Reporting Center Newsletter 17, no. 1 (January - April 2014)] http://dmsc2.dmsc.moph.go.th/webroot/drug/surveillance/newsletter/newsletter17-1-2557.pdf (accessed June 2, 2015)